05 March 2024
05 March 2024
In clinical trials, 64% of subjects showed no cancer progression after one year of treatment with dostarlimab.
For Rare Disease Day, several panels organised by the FDA discussed the importance overcoming accessibility barriers during drug development.
The EMA has validated the jointly developed TROP2-directed therapy for patients with breast or lung cancer following positive Phase III data.
The designation brings development incentives for A2 Bio, including tax credits for clinical trial costs.
The deal facilitates the vertical integration of Telix's supply chain and manufacturing.
CRISPR technology works with remarkable specificity to rectify non-functional genes.
The funding will support the evaluation of Taplucanium in a Phase IIb clinical trial in patients with chronic cough.
Panama’s government expects to be a pioneer in the region through the centralisation of drug procurement.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
